Home/ Stocks/ SNSE

Sensei Biotherapeutics, Inc. Common Stock

SNSE XNAS

$23.40 -0.36 (-1.52%) ▼ 15-min delayed

Open

$23.76

High

$25.23

Low

$22.75

Volume

16.2K

Market Cap

$31.38M

About Sensei Biotherapeutics, Inc. Common Stock

Sensei Biotherapeutics Inc is a clinical-stage biotechnology company engaged in the development of therapies targeting cancer through multi-node inhibition of oncogenic pathways. The company's lead program, PIKTOR, is an investigational oral combination therapy designed to inhibit multiple nodes of the PI3K/AKT/mTOR pathway and is being evaluated for the treatment of endometrial and breast cancers. In addition, the company is advancing other pipeline programs targeting tumor metabolism and signaling pathways.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 29 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$0	$-21,085,000	$-16.72
FY 2025	$0	$-21,085,000	$-16.72
Q3 2025	$0	$-4,569,000	$-3.62
Q2 2025	$0	$-4,936,000	$-3.91

Earnings & Analyst Ratings

Next Earnings: Mon, Aug 3, 2026

Calendar →

Related Market News

No specific coverage for SNSE yet. Check out our latest market news or earnings calendar.

Get SNSE Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Sensei Biotherapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.